ArticleInternational journal of general medicine2025
Combination of iLux Photothermal Pulsation Therapy with 0.05% Cyclosporine in the Treatment of Meibomian Gland Dysfunction: A Clinical Study.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to investigate the effect of iLux with 0.05% cyclosporine in the treatment of meibomian gland dysfunction. Methods and Materials: In retrospective analysis, 72 patients of meibomian gland dysfunction were selected and divided into combination groups according to different treatment methods (n=32, iLux + 0.05% cyclosporine ophthalmic fluid) and the conventional group (n=44, 0.05% cyclosporine ophthalmic fluid). Compare the two groups of baseline data and clinical efficacy difference, compare the two groups after treatment eye symptoms, eye surface disease index score change. Results: Overall response rate of the combined group was higher than the conventional group (P <0.05). Post-treatment, both groups were improved differently (P <0.05), however, in the combined group, ocular symptom score, ocular surface disease index, conjunctival congestion score, corneal fluorescent staining score, meibomian gland (ostium condition score, lipid secretion shape score, deletion score) and interleukin-6, interleukin-1 β were all lower than those in the conventional group, The non-invasive mean tear film break-up time (NIBUTav), non-invasive first tear film break-up time (NIBUTf) and tear meniscus height in the combined group were higher than the conventional group (P <0.05). Conclusion: ILux meibomian gland photothermal pulsation complex therapy instrument combined with 0.05% cyclosporine ophthalmic solution for the treatment of meibomian gland dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.